Genesis Biotechnology Group


Genesis Drug Discovery & Development (GD3) is a fully integrated CRO providing services to support drug discovery programs of our clients from target discovery through IND filing and managing Phase I-III clinical trials. GD3 portfolio includes services for HTS and assay development, synthetic organic and medicinal chemistry DMPK/in-vivo pharmacology and safety toxicology as well clinical trial services for the regulatory approval of novel drug and medical device products.